← back to search

Stephanie A. Harris

SSM Health Care · CA
Area of research
Immunology · Infectious Diseases
Research interest
Research interests include Tuberculosis Research and Epidemiology, Immune responses and vaccinations, Immunodeficiency and Autoimmune Disorders, and Mycobacterium research and diagnosis.
h-index
25
citations
11,345
works
55
NIH funding
primary concept
Medicine
email

Recent publications

Inflammation and immune activation are associated with risk of Mycobacterium tuberculosis infection in BCG-vaccinated infants
Nature Communications 2022cited by 20position: middledoi
Induction of Functional Specific Antibodies, IgG-Secreting Plasmablasts and Memory B Cells Following BCG Vaccination
Frontiers in Immunology 2022cited by 19position: middledoi
A non-human primate in vitro functional assay for the early evaluation of TB vaccine candidates
npj Vaccines 2021cited by 20position: middledoi
The in vitro direct mycobacterial growth inhibition assay (MGIA) for the early evaluation of TB vaccine candidates and assessment of protective immunity: a protocol for non-human primate cells
F1000Research 2021cited by 10position: middledoi
The in vitro direct mycobacterial growth inhibition assay (MGIA) for the early evaluation of TB vaccine candidates and assessment of protective immunity: a protocol for non-human primate cells
F1000Research 2021cited by 4position: middledoi
T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial
Nature Medicine 2020cited by 641position: middledoi
Tools for Assessing the Protective Efficacy of TB Vaccines in Humans: in vitro Mycobacterial Growth Inhibition Predicts Outcome of in vivo Mycobacterial Infection
Frontiers in Immunology 2020cited by 33position: middledoi
Cytomegalovirus infection is a risk factor for tuberculosis disease in infants
JCI Insight 2019cited by 63position: middledoi
Immunological correlates of mycobacterial growth inhibition describe a spectrum of tuberculosis infection
Scientific Reports 2018cited by 56position: middledoi
The influence of haemoglobin and iron on in vitro mycobacterial growth inhibition assays
Scientific Reports 2017cited by 33position: middledoi
Assay optimisation and technology transfer for multi-site immuno-monitoring in vaccine trials
PLoS ONE 2017cited by 8position: middledoi
T-cell activation is an immune correlate of risk in BCG vaccinated infants
Nature Communications 2016cited by 271position: middledoi
Gene Expression and Cytokine Profile Correlate With Mycobacterial Growth in a Human BCG Challenge Model
The Journal of Infectious Diseases 2014cited by 35position: middledoi
Inflammatory and myeloid-associated gene expression before and one day after infant vaccination with MVA85A correlates with induction of a T cell response
BMC Infectious Diseases 2014cited by 23position: middledoi
Inhibition of Mycobacterial Growth<i>In Vitro</i>following Primary but Not Secondary Vaccination with Mycobacterium bovis BCG
Clinical and Vaccine Immunology 2013cited by 84position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Helen McShane · University of Oxford12 papers (2013–2022)Iman Satti · London School of Hygiene & Tropical Medicine11 papers (2013–2022) · 10 papers (2013–2022)Helen A. Fletcher · London School of Hygiene & Tropical Medicine9 papers (2013–2022)Matthew K. O’Shea · University of Birmingham8 papers (2014–2022) · 5 papers (2020–2022)Andrew White · University of Alabama in Huntsville5 papers (2017–2022)Magali Matsumiya · London School of Hygiene & Tropical Medicine4 papers (2014–2020)Daniel Wright · NIHR Research Delivery Network4 papers (2021–2022) · 4 papers (2021–2022)Sally Sharpe · UK Health Security Agency4 papers (2017–2021)Charelle Boot · Royal Netherlands Academy of Arts and Sciences3 papers (2021–2021) · 3 papers (2021–2021)Joel N. Meyer · Duke University3 papers (2013–2020)Lisa Stockdale · University of Oxford3 papers (2014–2018) · 3 papers (2021–2021)Steven G. Smith · London School of Hygiene & Tropical Medicine3 papers (2017–2022) · 3 papers (2021–2021)Charlotte Sarfas · UK Health Security Agency3 papers (2021–2021)Mark Hatherill · University of Cape Town2 papers (2014–2022)